71 Integrated Spatial Multi-omics Reveals Tumour Immune Microenvironment Programmes Underlying Durable Response and Resistance to Dual ICI Therapy in ccRCC

肾透明细胞癌 转录组 肾癌 免疫检查点 免疫系统 肿瘤异质性 医学 肾细胞癌 癌症研究 肿瘤微环境 免疫疗法 抗体 癌症 肾切除术 活检 靶向治疗 细胞 T细胞 表型 PD-L1 肿瘤科 癌细胞 肾 癌 BAP1型 基因表达谱 液体活检 肿瘤浸润淋巴细胞 计算生物学 生物
作者
Zayd Tippu,Anne-Laure Cattin,Matouš Elphick,Kevin Mulder,Laura Marandino,Barbara Ibarzo Yus,Edward H. Arbe-Barnes,Sara Lopez Tamargo,Elizabeth Appleton,Stephanie Hepworth,Nisha Bhardwaj,Teena Thakur,Fiona Byrne,Kim Edmonds,Eleanor Carlyle,Sarah Rudman,Antonio Rullan,Koen van der Mijn,James Larkin,Axel Bex
出处
期刊:Oncologist [AlphaMed Press]
卷期号:31 (Supplement_3)
标识
DOI:10.1093/oncolo/oyag312.072
摘要

Abstract Background Combination immune checkpoint inhibitor (ICI) approaches are now standard of care for advanced clear cell renal cell carcinoma (ccRCC), yet validated biomarkers to guide selection of optimal combination regimens remain lacking. A key rationale for combined PD-1/CTLA-4 inhibition is the subset of patients achieving durable responses. The tumour immune microenvironment (TiME) is increasingly recognised as a key determinant of this benefit, yet its cellular composition, functional state and spatial organisation, and how these evolve under dual ICI therapy, remain undefined. Methods Tumour specimens from 30 metastatic ccRCC patients across two independent cohorts (TRACERx Renal and the Netherlands Cancer Institute; NKI) were subject to longitudinal multi-modal profiling, all of whom underwent deferred cytoreductive nephrectomy following treatment with combined CTLA-4 (Ipilimumab) and PD-1 (Nivolumab) inhibition. Patients were classified as durable responders (DR; no documented progression event; median follow-up 40.8 months) or as having acquired resistance (AR; initial CR/PR/SD > 6 months prior to progression). Where available, matched pre-treatment biopsy material and multi-regional post-treatment surgical specimens underwent multi-modal spatial profiling (n = 116 tumour regions), co-registering high-plex protein imaging (66-plex antibody panel; Akoya PhenoCycler), with spatial transcriptomics (RNA in situ platform targeting 480 kidney tumour-specific genes; 10x Genomics Xenium) on the same tissue sections, enabling simultaneous protein and transcriptomic characterisation of the TiME at single-cell resolution. In a subset (n = 8; n = 28 tumour regions), single-cell RNA sequencing with paired TCR and BCR sequencing was performed to resolve treatment-induced clonotypic and phenotypic dynamics within T and B cell compartments. Results Dual ICI therapy induced consistent immune remodelling across the cohort irrespective of response, characterised by increases in B cells and CD8+ T cells and a reduction in monocytes/macrophages. At baseline, durable response was associated with increased pericyte coverage of tumour vasculature, whilst acquired resistance patients exhibited decreased pericyte coverage alongside elevated CD39 expression on tumour endothelial cells, implicating dysfunctional, immunosuppressive vasculature as an early determinant of resistance. Post-treatment, durable responders demonstrated enrichment of CCR7+ dendritic cell (DC) niches containing CD4+ T cells, CD8+ T cells and B cells across tumour and stromal compartments, alongside monocytes/macrophages and NK cells within tumour regions. By contrast, acquired resistance CCR7+ DC niches lacked specific immune cell enrichment, displayed dysregulated transcriptional programmes. Acquired resistance was further characterised by enrichment of TREM2+ immunosuppressive macrophages and peri-vascular spatial interactions between macrophages and CD4+ T cells, defining an immunosuppressive niche. scRNA-seq with paired TCR sequencing identified novel and shared memory/resident T-cell clonotypes enriched in durable responders, whilst clonally expanded IgG2 plasma cells were orthogonally validated by BCR sequencing and spatial profiling as a hallmark of durable response. Conclusions Using an integrated multi-omic spatial framework combining high-plex proteomics, single-cell and spatial transcriptomics, we provide a comprehensive characterisation of TiME remodelling under dual ICI therapy in ccRCC. Durable response is preceded at baseline by a normalised vascular phenotype and is subsequently characterised post-treatment by the presence of coordinated CCR7+ DC niches, clonally expanded IgG2 plasma cells, and the emergence of memory/ resident T-cell clonotypes. Conversely, acquired resistance is characterised by an immune exclusion programme, defined by dysfunctional vasculature, TREM2+ macrophage enrichment, impaired DC niche organisation and peri-vascular immunosuppressive niches. By identifying spatially resolved cellular niches underpinning differential responses to combination ICI approaches, this work provides insights into biomarkers of durable response, whilst providing a framework for rational combination strategies to overcome resistance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
MOhy发布了新的文献求助10
刚刚
烧灯续昼发布了新的文献求助10
刚刚
刚刚
852的应助被海棠听风采纳,获得10
刚刚
柯楠吴发布了新的文献求助10
刚刚
方源的应助被yeguxing33采纳,获得20
2秒前
睡醒精神好完成签到 ,获得积分10
2秒前
2秒前
3秒前
狂野的乐萱完成签到,获得积分10
3秒前
3秒前
落后的导师完成签到 ,获得积分10
3秒前
day_on完成签到,获得积分10
4秒前
4秒前
4秒前
4秒前
Tara发布了新的文献求助10
5秒前
殷勤的紫槐的应助被tony采纳,获得200
5秒前
丘比特的应助被干饭啦采纳,获得10
5秒前
5秒前
汉堡包的应助被ylyyyy采纳,获得10
6秒前
上官若男的应助被小明同学采纳,获得10
7秒前
7秒前
8秒前
齐是发布了新的文献求助10
9秒前
干净绫完成签到,获得积分10
9秒前
常樂完成签到 ,获得积分10
9秒前
拿铁完成签到 ,获得积分10
9秒前
康子浩发布了新的文献求助10
10秒前
10秒前
Ava的应助被路遥采纳,获得10
10秒前
嘻嘻完成签到 ,获得积分10
10秒前
我要吃饭完成签到,获得积分10
10秒前
张大大发布了新的文献求助10
11秒前
香菜炒土豆完成签到,获得积分10
11秒前
小二郎的应助被谨慎的秋烟采纳,获得10
12秒前
仲棠完成签到,获得积分20
12秒前
null的应助被PO采纳,获得10
12秒前
13秒前
Lucas的应助被akakns采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163746
求助须知:如何正确求助?哪些是违规求助? 9557874
关于积分的说明 21742203
捐赠科研通 7754407
什么是DOI,文献DOI怎么找? 3428345
关于科研通互助平台的介绍 2553000
邀请新用户注册赠送积分活动 2472945